4
MARKET OVERVIEW
Capitalize on rising health consciousness and untapped opportunities in personalized nutrition to drive growth.
42
4.2.1.1
RISING HEALTH CONSCIOUSNESS AMONG CONSUMERS
4.2.1.2
INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES
GROWING AGING POPULATION AND RISING PREVALENCE OF
4.2.2.1
INCONSISTENCY IN REGULATORY NORMS
4.2.2.2
PRICE VOLATILITY OF RAW MATERIALS
4.2.3.1
GROWING DEMAND FOR NATURAL AND PLANT-BASED INGREDIENTS
4.2.3.2
RISING NEED FOR PERSONALIZED NUTRITION AND CUSTOMIZED PRODUCTS
4.2.3.3
UNTAPPED APPLICATIONS
4.2.4.1
LACK OF CONSUMER AWARENESS REGARDING SPECIFIC HEALTH BENEFITS
4.2.4.2
HIGH RESEARCH AND DEVELOPMENT COSTS
4.3
UNMET NEEDS AND WHITE SPACES
4.3.1
UNMET NEEDS IN VITAMIN K2 MARKET
4.3.2
WHITE SPACE OPPORTUNITIES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4.1
INTERCONNECTED MARKETS
4.4.2
CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
4.5.1
KEY MOVES AND STRATEGIC FOCUS
5
INDUSTRY TRENDS
Navigate competitive dynamics and leverage macroeconomic shifts to capitalize on emerging industry opportunities.
55
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
INTENSITY OF COMPETITIVE RIVALRY
5.1.2
BARGAINING POWER OF SUPPLIERS
5.1.3
BARGAINING POWER OF BUYERS
5.1.4
THREAT OF SUBSTITUTES
5.1.5
THREAT OF NEW ENTRANTS
5.2
MACROECONOMICS OUTLOOK
5.2.1.1
MACROECONOMIC INDICATORS
5.2.1.1.1
RISING WORLD GDP AND POPULATION
5.2.1.1.2
RISE IN HEALTH CONCERNS AND DISEASE INCIDENCES
5.3.1
RESEARCH AND DEVELOPMENT
5.3.2
RAW MATERIAL SOURCING
5.3.3
PRODUCTION AND PROCESSING
5.3.5
MARKETING, DISTRIBUTION, & SALES
AVERAGE SELLING PRICE (ASP) TREND, BY PRODUCT TYPE,
AVERAGE SELLING PRICE (ASP) TREND, BY REGION,
5.6.1
IMPORT ANALYSIS: VITAMINS AND THEIR DERIVATIVES
5.6.2
EXPORT ANALYSIS: VITAMINS AND THEIR DERIVATIVES
5.7
KEY CONFERENCES AND EVENTS, 2026–2027
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9
INVESTMENT AND FUNDING SCENARIO
5.10.1
GNOSIS BY LESAFFRE – LAUNCH OF MENAQ7 OLIVE OIL
5.10.2
BALCHEM CORP.– ACQUISITION OF KAPPA BIOSCIENCE
5.11
IMPACT OF 2025 US TARIFF – VITAMIN K2 MARKET
5.11.2
PRICE IMPACT ANALYSIS
5.11.3
IMPACT ON COUNTRIES/REGIONS
5.11.4
IMPACT ON END-USE INDUSTRIES
TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS,
6.1.1.1
FERMENTATION TECHNOLOGY
6.1.1.2
BIOREACTOR PROCESS CONTROL TECHNOLOGY
6.1.2
COMPLEMENTARY ANALYSIS
6.1.2.1
ENCAPSULATION TECHNOLOGY
6.1.2.2
SPRAY DRYING TECHNOLOGY
6.1.3
ADJACENT TECHNOLOGIES
6.1.3.1
SYNTHETIC BIOLOGY
6.1.3.2
CONTINUOUS MANUFACTURING TECHNOLOGY
6.1.4
TECHNOLOGY/PRODUCT ROADMAP
6.1.4.1
SHORT-TERM | PROCESS OPTIMIZATION & HIGH-PURITY INGREDIENT EXPANSION
6.1.4.2
MID-TERM | PERSONALIZED NUTRITION & SUSTAINABLE BIOPROCESSING
6.1.4.3
LONG-TERM | SYNTHETIC BIOLOGY & NEXT-GENERATION PRECISION HEALTH
6.3.1
AI-DRIVEN PRECISION FERMENTATION: OPTIMIZING VITAMIN K2 PRODUCTION
SYNTHETIC BIOLOGY: ENGINEERING HIGH-PERFORMANCE
PRECISION NUTRITION & PERSONALIZED SUPPLEMENTATION:
ADVANCED DELIVERY SYSTEMS & SMART FORMULATIONS:
DIGITAL MANUFACTURING & SMART QUALITY CONTROL:
6.4
IMPACT OF GENERATIVE AI ON VITAMIN K2 MARKET
6.4.2
CASE STUDIES OF AI IMPLEMENTATION IN VITAMIN K2 MARKET
INTERCONNECTED ADJACENT ECOSYSTEM AND
6.4.4
CLIENTS' READINESS TO ADOPT GENERATIVE AI IN VITAMIN K2 MARKET
6.5
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
Navigate evolving regulations and sustainability mandates to future-proof your global operations.
84
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.3
LABELING REQUIREMENTS AND CLAIMS
7.1.4
ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS
7.1.4.1
ENHANCED INGREDIENT TRACEABILITY AND SUPPLY CHAIN TRANSPARENCY
7.1.4.2
GREATER HARMONIZATION OF GLOBAL REGULATORY STANDARDS
7.1.4.3
STRICTER SUSTAINABILITY AND RESPONSIBLE MANUFACTURING REQUIREMENTS
7.1.4.4
DIGITAL COMPLIANCE, SMART MANUFACTURING, AND QUALITY MANAGEMENT
EXPANDED REGULATION OF NOVEL PRODUCTION TECHNOLOGIES AND
7.1.4.6
STRENGTHENED LABELING AND CONSUMER TRANSPARENCY REQUIREMENTS
7.2
SUSTAINABILITY INITIATIVES
7.2.1
SUSTAINABLE SOURCING
7.2.2
CARBON FOOTPRINT REDUCTION INITIATIVES
7.2.3
CIRCULAR ECONOMY APPROACHES
7.3
IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
7.4
CERTIFICATIONS, LABELING, ECO-STANDARDS
8
CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
Unlock profitability by addressing unmet needs and stakeholder criteria in the Vitamin K2 market.
94
8.1
DECISION-MAKING PROCESS
8.2
KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.3
ADOPTION BARRIERS AND INTERNAL CHALLENGES
8.4
UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN
8.6.2
MARGIN OPPORTUNITIES, BY PRODUCT TYPE
9
VITAMIN K2 MARKET, BY FUNCTION
Market Size & Growth Rate Forecast Analysis
104
9.2
BONE AND CARDIOVASCULAR HEALTH
9.2.1
RISING PREVALENCE OF OSTEOPOROSIS AND CARDIOVASCULAR DISORDERS TO DRIVE VITAMIN K2 ADOPTION IN BONE AND CARDIOVASCULAR HEALTH FORMULATIONS
9.3
BLOOD HEALTH AND CLOTTING
9.3.1
EFFICACY IN MANAGING CLOTTING DISORDERS TO BOOST MARKET GROWTH
9.4
ANTI-INFLAMMATORY AND IMMUNITY
9.4.1
THERAPEUTIC POTENTIAL AND IMMUNITY-SUPPORTING PROPERTIES TO SUPPORT MARKET GROWTH
10
VITAMIN K2 MARKET, BY PRODUCTION TECHNOLOGY
108
10.2
NATURAL FERMENTATION
10.2.1
PREFERRED PRODUCTION TECHNOLOGY FOR PREMIUM VITAMIN K2 (MK-7) DUE TO SUPERIOR BIOAVAILABILITY, NATURAL ORIGIN, AND STRONG CONSUMER ACCEPTANCE
10.3.1
COST-EFFECTIVE PRODUCTION AND HIGH MANUFACTURING SCALABILITY, PARTICULARLY FOR VITAMIN K2 (MK-4)
10.4
BIOTECHNOLOGICAL FERMENTATION
10.4.1
ENHANCES PRODUCTION EFFICIENCY THROUGH ADVANCED MICROBIAL ENGINEERING AND PRECISION BIOPROCESS TECHNOLOGIES
10.5
OTHER PRODUCTION TECHNOLOGIES
11
VITAMIN K2 MARKET, BY PRODUCT TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million and Tons | 17 Data Tables
111
11.2.1
HIGH BIOAVAILABILITY TO PROPEL MARKET GROWTH
POTENTIAL BENEFITS IN BONE AND CARDIOVASCULAR HEALTH TO
12
VITAMIN K2 MARKET, BY SOURCE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 6 Data Tables
119
12.2.1
INCREASING CONSUMER PREFERENCE FOR NON-GMO SUPPLEMENTS TO BOOST MARKET GROWTH
12.3.1
LOW PRODUCTION COST TO DRIVE MARKET
13
VITAMIN K2 MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 20 Data Tables
124
13.2.1
GROWING ADOPTION OF PREVENTIVE NUTRITION AND CLINICALLY SUPPORTED DIETARY SUPPLEMENTS TO DRIVE SEGMENT
13.3
FUNCTIONAL FOOD & BEVERAGES
GROWING DEMAND FOR FORTIFIED FUNCTIONAL FOODS TO
RISING INVESTMENTS FOR DEVELOPING NEW FORMULATIONS TO
14
VITAMIN K2 MARKET, BY APPLICATION FORM
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 8 Data Tables
134
ABILITY TO CATER TO DIVERSE CONSUMER NEEDS AND
14.3
POWDER & CRYSTALLINE
14.3.1
SURGING DEMAND FOR CUSTOMIZABLE DOSAGES AND HIGH PURITY TO PROPEL MARKET GROWTH
14.4.1
GROWING NEED FOR SUPPLEMENTS WITH ENHANCED BIOAVAILABILITY TO BOOST SEGMENT GROWTH
15
VITAMIN K2 MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 12 Countries | 108 Data Tables.
139
15.2.1.1
GROWING AWARENESS ABOUT PREVENTIVE HEALTH MEASURES TO DRIVE MARKET
15.2.2.1
INCREASING FOCUS ON PREVENTIVE HEALTHCARE AND NATURAL PRODUCTS TO PROPEL MARKET
15.2.3.1
HIGH PREVALENCE OF CHRONIC LIFESTYLE DISEASES TO DRIVE MARKET
15.3.1.1
RISING FOCUS ON PROACTIVE HEALTHCARE TO DRIVE MARKET
15.3.2.1
INVESTMENTS IN R&D AND PRODUCT INNOVATION TO BOOST MARKET GROWTH
15.3.3.1
RAPIDLY AGING POPULATION TO PROPEL MARKET GROWTH
15.3.4.1
AGING POPULATION AND PREVENTIVE HEALTHCARE TRENDS TO SUPPORT VITAMIN K2 ADOPTION
15.3.5.1
GROWING CONSUMER INTEREST IN HEALTH SUPPLEMENTS TO DRIVE DEMAND
15.4.1.1
SURGING USE OF DIGITAL MEDIA TO DISSEMINATE HEALTHCARE INFORMATION TO PROPEL MARKET
15.4.2.1
CONSUMER PREFERENCES FOR NATURAL HEALTHCARE SOLUTIONS TO BOOST MARKET GROWTH
15.4.3.1
STRATEGIC MARKET PENETRATION INITIATIVES BY VARIOUS COMPANIES TO DRIVE MARKET
15.4.4
AUSTRALIA AND NEW ZEALAND
15.4.4.1
CHANGING CONSUMER PREFERENCES AND INCREASING HEALTH CONSCIOUSNESS TO DRIVE DEMAND
15.4.5
REST OF ASIA PACIFIC
15.5.1.1
RISING PREVENTIVE HEALTHCARE AWARENESS AND EXPANDING NUTRACEUTICAL INDUSTRY TO SUPPORT MARKET GROWTH
15.5.2
MIDDLE EAST & AFRICA
15.5.2.1
RISING HEALTHCARE INVESTMENTS AND GROWING PREVENTIVE NUTRITION AWARENESS TO SUPPORT MARKET GROWTH
16
COMPETITIVE LANDSCAPE
Uncover top strategies driving key players' dominance and revenue growth in the competitive landscape.
176
16.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN 2021–2026
16.3
REVENUE ANALYSIS, 2023–2025
16.4
MARKET SHARE ANALYSIS, 2025
16.4.2
NOVONESIS GROUP (MENAQUINGOLD)
16.4.3
GNOSIS BY LESAFFRE (MENAQ7)
16.4.4
BALCHEM CORP. (K2VITAL)
16.4.5
GUANGDONG SUNGEN BIOSCIENCE CO., LTD. (ESSEK2)
16.4.6
J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.) (MENNATO)
16.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
16.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
16.5.5.1
COMPANY FOOTPRINT
16.5.5.2
REGION FOOTPRINT
16.5.5.3
APPLICATION FOOTPRINT
16.5.5.4
PRODUCT TYPE FOOTPRINT
16.6
COMPANY EVALUATION MATRIX: DISTRIBUTORS/SUPPLIERS
16.6.1
PROGRESSIVE COMPANIES
16.6.2
RESPONSIVE COMPANIES
16.6.5
COMPETITIVE BENCHMARKING: DISTRIBUTORS/SUPPLIERS, 2025
16.6.5.1
DETAILED LIST OF KEY DISTRIBUTORS/SUPPLIERS
16.6.5.2
COMPETITIVE BENCHMARKING OF KEY DISTRIBUTORS/SUPPLIERS
16.7
COMPANY VALUATION AND FINANCIAL METRICS
16.8
COMPETITIVE SCENARIO
16.8.1
PRODUCT LAUNCHES/DEVELOPMENTS
16.8.4
OTHER DEVELOPMENTS
17
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
199
17.1
KEY PLAYERS (MANUFACTURERS)
17.1.1
GNOSIS BY LESAFFRE
17.1.1.1
BUSINESS OVERVIEW
17.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
17.1.1.3
RECENT DEVELOPMENTS
17.1.1.3.1
PRODUCT LAUNCHES/DEVELOPMENTS
17.1.1.4.2
STRATEGIC CHOICES
17.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
17.1.3
J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.)
17.1.5
GUANGDONG SUNGEN BIOSCIENCE CO., LTD.
17.1.7
RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.
17.1.9
GF FERMENTECH CO., LTD.
17.1.10
ANGELYEAST CO., LTD.
17.1.11
GENEFERM BIOTECHNOLOGY CO., LTD.
17.1.12
NAKODA CHEMICALS LTD.
17.1.13
HAIHANG INDUSTRY CO., LTD.
17.1.15
KYOWA HAKKO U.S.A., INC.
17.2
DISTRIBUTORS/SUPPLIERS
17.2.1
SEEBIO BIOTECH (SHANGHAI) CO., LTD.
17.2.3
FALCON TRADING INTERNATIONAL
17.2.5
ATLANTIC CHEMICALS TRADING GMBH
18
RESEARCH METHODOLOGY
244
18.1.1.1
KEY DATA FROM SECONDARY SOURCES
18.1.2.1
KEY DATA FROM PRIMARY SOURCES
18.1.2.2
BREAKDOWN OF PRIMARY PROFILES
18.1.2.3
KEY INSIGHTS FROM INDUSTRY EXPERTS
18.2
MARKET SIZE ESTIMATION
18.2.2
SUPPLY-SIDE ANALYSIS
18.2.3
BOTTOM-UP APPROACH (DEMAND SIDE)
18.3
DATA TRIANGULATION AND MARKET BREAKUP
18.4
RESEARCH ASSUMPTIONS
18.5
RESEARCH LIMITATIONS AND RISK ASSESSMENT
19
ADJACENT AND RELATED MARKETS
254
19.2
RESEARCH LIMITATIONS
19.3
DIETARY SUPPLEMENTS MARKET
20.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
20.3
CUSTOMIZATION OPTIONS
TABLE 1
INCLUSIONS AND EXCLUSIONS
TABLE 2
USD EXCHANGE RATES, 2022–2025
TABLE 3
IMPACT OF PORTER’S FIVE FORCES ON VITAMIN K2 MARKET
TABLE 4
VITAMIN K2 MARKET: SUPPLY SIDE (ECOSYSTEM)
TABLE 5
AVERAGE SELLING PRICE (ASP) TREND, BY PRODUCT TYPE, 2022–2025 (USD/TONS)
TABLE 6
AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TONS)
TABLE 7
TOP IMPORTERS OF VITAMINS AND THEIR DERIVATIVES, 2021–2025 (USD MILLION)
TABLE 8
TOP EXPORTERS OF VITAMINS AND THEIR DERIVATIVES, 2021–2025 (USD MILLION)
TABLE 9
VITAMIN K2 MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026–2027
TABLE 10
PATENTS PERTAINING TO VITAMIN K2 MARKET, 2024–2026
TABLE 11
VITAMIN K2 MARKET: CASE STUDIES RELATED TO GENERATIVE AI IMPLEMENTATION
TABLE 12
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
TABLE 13
NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14
EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15
ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16
INTERNATIONAL: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17
GLOBAL INDUSTRY STANDARDS IN VITAMIN K2 MARKET
TABLE 18
LABELING REQUIREMENTS AND CLAIMS IN VITAMIN K2 MARKET
TABLE 19
CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN VITAMIN K2 MARKET
TABLE 20
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VITAMIN K2 PRODUCT TYPES
TABLE 21
KEY BUYING CRITERIA FOR VITAMIN K2 PRODUCT TYPES
TABLE 22
UNMET NEEDS IN VITAMIN K2 MARKET, BY APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN
TABLE 23
COST DYNAMICS IN VITAMIN K2 MARKET
TABLE 24
MARGIN OPPORTUNITIES IN VITAMIN K2 MARKET, BY PRODUCT TYPE
TABLE 25
PRODUCTION TECHNOLOGY APPLIED BY KEY PLAYERS
TABLE 26
PRODUCT TYPE: OVERVIEW
TABLE 27
VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 28
VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 29
VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (TON)
TABLE 30
VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (TON)
TABLE 31
MK7: VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 32
MK7: VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 33
MK7: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 34
MK7: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 35
MK7: VITAMIN K2 MARKET, BY REGION, 2022–2025 (TON)
TABLE 36
MK7: VITAMIN K2 MARKET, BY REGION, 2026–2031 (TON)
TABLE 37
MK4: VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 38
MK4: VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 39
MK4: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 40
MK4: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 41
MK4: VITAMIN K2 MARKET, BY REGION, 2022–2025 (TON)
TABLE 42
MK4: VITAMIN K2 MARKET, BY REGION, 2026–2031 (TON)
TABLE 43
VITAMIN K2 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 44
VITAMIN K2 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 45
NATURAL: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 46
NATURAL: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 47
SYNTHETIC: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 48
SYNTHETIC: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 49
VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 50
VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 51
HEALTH SUPPLEMENTS: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 52
HEALTH SUPPLEMENTS: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 53
HEALTH SUPPLEMENTS: MK7 VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 54
HEALTH SUPPLEMENTS: MK7 VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 55
HEALTH SUPPLEMENTS: MK4 VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 56
HEALTH SUPPLEMENTS: MK4 VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 57
FUNCTIONAL FOOD & BEVERAGES: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 58
FUNCTIONAL FOOD & BEVERAGES: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 59
FUNCTIONAL FOOD & BEVERAGES: MK7 VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 60
FUNCTIONAL FOOD & BEVERAGES: MK7 VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 61
FUNCTIONAL FOOD & BEVERAGES: MK4 VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 62
FUNCTIONAL FOOD & BEVERAGES: MK4 VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 63
PHARMACEUTICALS: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 64
PHARMACEUTICALS: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 65
PHARMACEUTICALS: MK7 VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 66
PHARMACEUTICALS: MK7 VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 67
PHARMACEUTICALS: MK4 VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 68
PHARMACEUTICALS: MK4 VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 69
VITAMIN K2 MARKET, BY APPLICATION FORM, 2022–2025 (USD MILLION)
TABLE 70
VITAMIN K2 MARKET, BY APPLICATION FORM, 2026–2031 (USD MILLION)
TABLE 71
CAPSULES & TABLETS: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 72
CAPSULES & TABLETS: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 73
POWDER & CRYSTALLINE: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 74
POWDER & CRYSTALLINE: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 75
LIQUIDS: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 76
LIQUIDS: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 77
VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 78
VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 79
VITAMIN K2 MARKET, BY REGION, 2022–2025 (TON)
TABLE 80
VITAMIN K2 MARKET, BY REGION, 2026–2031 (TON)
TABLE 81
NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2022–2025 (USD MILLION)
TABLE 82
NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2026–2031 (USD MILLION)
TABLE 83
NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2022–2025 (TON)
TABLE 84
NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2026–2031 (TON)
TABLE 85
NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 86
NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 87
NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (TON)
TABLE 88
NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (TON)
TABLE 89
NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION FORM, 2022–2025 (USD MILLION)
TABLE 90
NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION FORM, 2026–2031 (USD MILLION)
TABLE 91
NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 92
NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 93
NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 94
NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 95
NORTH AMERICA: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 96
NORTH AMERICA: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 97
NORTH AMERICA: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 98
NORTH AMERICA: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 99
US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 100
US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 101
CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 102
CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 103
MEXICO: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 104
MEXICO: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 105
EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2022–2025 (USD MILLION)
TABLE 106
EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2026–2031 (USD MILLION)
TABLE 107
EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2022–2025 (TON)
TABLE 108
EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2026–2031 (TON)
TABLE 109
EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 110
EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 111
EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (TON)
TABLE 112
EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (TON)
TABLE 113
EUROPE: VITAMIN K2 MARKET, BY APPLICATION FORM, 2022–2025 (USD MILLION)
TABLE 114
EUROPE: VITAMIN K2 MARKET, BY APPLICATION FORM, 2026–2031 (USD MILLION)
TABLE 115
EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 116
EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 117
EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 118
EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 119
EUROPE: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 120
EUROPE: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 121
EUROPE: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 122
EUROPE: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 123
GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 124
GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 125
FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 126
FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 127
UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 128
UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 129
ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 130
ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 131
SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 132
SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 133
REST OF EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 134
REST OF EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 135
ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2022–2025 (USD MILLION)
TABLE 136
ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2026–2031 (USD MILLION)
TABLE 137
ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2022–2025 (TON)
TABLE 138
ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2026–2031 (TON)
TABLE 139
ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 140
ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 141
ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (TON)
TABLE 142
ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (TON)
TABLE 143
ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION FORM, 2022–2025 (USD MILLION)
TABLE 144
ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION FORM, 2026–2031 (USD MILLION)
TABLE 145
ASIA PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 146
ASIA PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 147
ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 148
ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 149
ASIA PACIFIC: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 150
ASIA PACIFIC: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 151
ASIA PACIFIC: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 152
ASIA PACIFIC: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 153
CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 154
CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 155
JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 156
JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 157
INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 158
INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 159
AUSTRALIA AND NEW ZEALAND: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 160
AUSTRALIA AND NEW ZEALAND: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 161
REST OF ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 162
REST OF ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 163
REST OF THE WORLD: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 164
REST OF THE WORLD: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 165
REST OF THE WORLD: VITAMIN K2 MARKET, BY REGION, 2022–2025 (TON)
TABLE 166
REST OF THE WORLD: VITAMIN K2 MARKET, BY REGION, 2026–2031 (TON)
TABLE 167
REST OF THE WORLD: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 168
REST OF THE WORLD: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 169
REST OF THE WORLD: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (TON)
TABLE 170
REST OF THE WORLD: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (TON)
TABLE 171
REST OF THE WORLD: VITAMIN K2 MARKET, BY APPLICATION FORM, 2022–2025 (USD MILLION)
TABLE 172
REST OF THE WORLD: VITAMIN K2 MARKET, BY APPLICATION FORM, 2026–2031 (USD MILLION)
TABLE 173
REST OF THE WORLD: VITAMIN K2 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 174
REST OF THE WORLD: VITAMIN K2 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 175
REST OF THE WORLD: VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 176
REST OF THE WORLD: VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 177
REST OF THE WORLD: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 178
REST OF THE WORLD: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 179
REST OF THE WORLD: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 180
REST OF THE WORLD: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 181
SOUTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 182
SOUTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 183
MIDDLE EAST & AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
TABLE 184
MIDDLE EAST & AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
TABLE 185
OVERVIEW OF STRATEGIES ADOPTED BY KEY VITAMIN K2 VENDORS, 2021–2026
TABLE 186
VITAMIN K2 MARKET: DEGREE OF COMPETITION
TABLE 187
VITAMIN K2 MARKET: REGION FOOTPRINT
TABLE 188
VITAMIN K2 MARKET: APPLICATION FOOTPRINT
TABLE 189
VITAMIN K2 MARKET: PRODUCT TYPE FOOTPRINT
TABLE 190
VITAMIN K2 MARKET: KEY DISTRIBUTORS/SUPPLIERS, 2025
TABLE 191
VITAMIN K2 MARKET: COMPETITIVE BENCHMARKING OF KEY DISTRIBUTORS/SUPPLIERS
TABLE 192
VITAMIN K2 MARKET: PRODUCT LAUNCHES/DEVELOPMENTS, 2021–JUNE 2026
TABLE 193
VITAMIN K2 MARKET: DEALS, 2021–JUNE 2026
TABLE 194
VITAMIN K2 MARKET: EXPANSIONS, 2021–JUNE 2026
TABLE 195
VITAMIN K2 MARKET: OTHER DEVELOPMENTS, 2021–JUNE 2026
TABLE 196
GNOSIS BY LESAFFRE: COMPANY OVERVIEW
TABLE 197
GNOSIS BY LESAFFRE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 198
GNOSIS BY LESAFFRE: PRODUCT LAUNCHES/DEVELOPMENTS
TABLE 199
GNOSIS BY LESAFFRE: DEALS
TABLE 200
BALCHEM CORP.: COMPANY OVERVIEW
TABLE 201
BALCHEM CORP.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 202
BALCHEM CORP.: PRODUCT LAUNCHES/DEVELOPMENTS
TABLE 203
BALCHEM CORP.: DEALS
TABLE 204
BALCHEM CORP.: EXPANSIONS
TABLE 205
J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.): COMPANY OVERVIEW
TABLE 206
J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.): PRODUCTS/SOLUTIONS/ SERVICES OFFERED
TABLE 207
J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.): PRODUCT LAUNCHES/DEVELOPMENTS
TABLE 208
J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.): DEALS
TABLE 209
NOVONESIS GROUP: COMPANY OVERVIEW
TABLE 210
NOVONESIS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 211
NOVONESIS GROUP: DEALS
TABLE 212
GUANGDONG SUNGEN BIOSCIENCE CO., LTD.: COMPANY OVERVIEW
TABLE 213
GUANGDONG SUNGEN BIOSCIENCE CO., LTD.: PRODUCTS/SOLUTIONS/ SERVICES OFFERED
TABLE 214
GUANGDONG SUNGEN BIOSCIENCE CO., LTD.: OTHER DEVELOPMENTS
TABLE 215
VESTA NUTRA: COMPANY OVERVIEW
TABLE 216
VESTA NUTRA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 217
RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 218
RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 219
RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: PRODUCT LAUNCHES/DEVELOPMENTS
TABLE 220
RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: OTHER DEVELOPMENTS
TABLE 221
MENADIONA: COMPANY OVERVIEW
TABLE 222
MENADIONA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 223
MENADIONA: PRODUCT LAUNCHES/DEVELOPMENTS
TABLE 224
GF FERMENTECH CO., LTD.: COMPANY OVERVIEW
TABLE 225
GF FERMENTECH CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 226
GF FERMENTECH CO., LTD.: PRODUCT LAUNCHES/DEVELOPMENTS
TABLE 227
GF FERMENTECH CO., LTD.: DEALS
TABLE 228
ANGELYEAST CO., LTD.: COMPANY OVERVIEW
TABLE 229
ANGELYEAST CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 230
ANGELYEAST CO., LTD.: EXPANSIONS
TABLE 231
GENEFERM BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 232
GENEFERM BIOTECHNOLOGY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 233
GENEFERM BIOTECHNOLOGY CO., LTD.: EXPANSIONS
TABLE 234
NAKODA CHEMICALS LTD.: COMPANY OVERVIEW
TABLE 235
NAKODA CHEMICALS LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 236
HAIHANG INDUSTRY CO., LTD.: COMPANY OVERVIEW
TABLE 237
HAIHANG INDUSTRY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 238
CHEMICEA LIMITED: COMPANY OVERVIEW
TABLE 239
CHEMICEA LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 240
KYOWA HAKKO U.S.A., INC.: BUSINESS OVERVIEW
TABLE 241
KYOWA HAKKO U.S.A., INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 242
SEEBIO BIOTECH (SHANGHAI) CO., LTD.: COMPANY OVERVIEW
TABLE 243
MAGNESIA GMBH: COMPANY OVERVIEW
TABLE 244
FALCON TRADING INTERNATIONAL: COMPANY OVERVIEW
TABLE 245
ABCO INDIA: COMPANY OVERVIEW
TABLE 246
ATLANTIC CHEMICALS TRADING GMBH: COMPANY OVERVIEW
TABLE 247
MARKETS ADJACENT TO VITAMIN K2 MARKET
TABLE 248
DIETARY SUPPLEMENTS MARKET, BY MODE OF APPLICATION, 2020–2023 (USD MILLION)
TABLE 249
DIETARY SUPPLEMENTS MARKET, BY MODE OF APPLICATION, 2024–2029 (USD MILLION)
TABLE 250
VITAMINS MARKET, BY SOURCE, 2017–2022 (USD MILLION)
TABLE 251
VITAMINS MARKET, BY SOURCE, 2023–2028 (USD MILLION)
FIGURE 2
VITAMIN K2 MARKET, 2022–2031
FIGURE 3
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN VITAMIN K2, 2022–JUNE 2026
FIGURE 4
DISRUPTIONS INFLUENCING GROWTH OF VITAMIN K2 MARKET
FIGURE 5
VITAMIN K2 MARKET: HIGH-GROWTH SEGMENTS, 2026–2031
FIGURE 6
ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 7
RISING DEMAND FOR PREVENTIVE HEALTHCARE AND NATURALLY FERMENTED VITAMIN K2 TO CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS
FIGURE 8
CAPSULES & TABLETS SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARES IN 2026
FIGURE 9
NATURAL SEGMENT TO DOMINATE MARKET IN 2026
FIGURE 10
HEALTH SUPPLEMENTS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
FIGURE 11
MK7 SEGMENT TO DOMINATE MARKET IN 2026
FIGURE 12
CAPSULES & TABLETS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
FIGURE 13
US TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
FIGURE 14
VITAMIN K2 MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15
HEALTH EXPENDITURE AS SHARE OF GDP FOR SELECTED COUNTRIES, 2014–2024
FIGURE 16
VITAMIN K2 MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 17
GDP TRENDS AND FORECAST OF MAJOR ECONOMIES, 2023–2030 (USD BILLION)
FIGURE 18
GLOBAL POPULATION GROWTH, 2000–2100 (BILLION)
FIGURE 19
GLOBAL TRENDS IN DEATHS DUE TO CVD, 1990–2030
FIGURE 20
VITAMIN K2 MARKET: VALUE CHAIN ANALYSIS
FIGURE 21
VITAMIN K2 MARKET: ECOSYSTEM ANALYSIS
FIGURE 22
AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TONS)
FIGURE 23
IMPORT OF HS CODE 293629, BY KEY COUNTRY, 2021–2025 (USD MILLION)
FIGURE 24
EXPORT OF HS CODE 293629, BY KEY COUNTRY, 2021–2025, (USD MILLION)
FIGURE 25
TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS
FIGURE 26
INVESTMENT AND FUNDING SCENARIO
FIGURE 27
NUMBER OF PATENTS APPLIED AND GRANTED, 2016–2026
FIGURE 28
FUTURE APPLICATIONS
FIGURE 29
VITAMIN K2 MARKET DECISION-MAKING FACTORS
FIGURE 30
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VITAMIN K2 PRODUCT TYPES
FIGURE 31
KEY BUYING CRITERIA FOR VITAMIN K2 PRODUCT TYPES
FIGURE 32
ADOPTION BARRIERS AND INTERNAL CHALLENGES
FIGURE 33
VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026 VS. 2031
FIGURE 34
VITAMIN K2 MARKET, BY SOURCE, 2026 VS. 2031
FIGURE 35
VITAMIN K2 MARKET, BY APPLICATION, 2026 VS. 2031
FIGURE 36
VITAMIN K2 MARKET, BY APPLICATION FORM, 2026 VS. 2031
FIGURE 37
ITALY TO RECORD HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 38
NORTH AMERICA: VITAMIN K2 MARKET SNAPSHOT
FIGURE 39
ASIA PACIFIC: VITAMIN K2 MARKET SNAPSHOT
FIGURE 40
REVENUE ANALYSIS OF KEY COMPANIES, 2023–2025 (USD BILLION)
FIGURE 41
SHARE OF LEADING COMPANIES IN VITAMIN K2 MARKET, 2025
FIGURE 42
COMPARATIVE ANALYSIS OF VENDOR BRANDS
FIGURE 43
VITAMIN K2 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 44
VITAMIN K2 MARKET: COMPANY FOOTPRINT
FIGURE 45
VITAMIN K2 MARKET: COMPANY EVALUATION MATRIX (DISTRIBUTORS/SUPPLIERS), 2025
FIGURE 46
COMPANY VALUATION OF KEY VITAMIN K2 VENDORS
FIGURE 47
EV/EBITDA OF KEY COMPANIES
FIGURE 48
BALCHEM CORP.: COMPANY SNAPSHOT
FIGURE 49
J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.): COMPANY SNAPSHOT
FIGURE 50
NOVONESIS GROUP: COMPANY SNAPSHOT
FIGURE 51
GENEFERM BIOTECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
FIGURE 52
VITAMIN K2 MARKET: RESEARCH DESIGN
FIGURE 53
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 54
MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 55
SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP
FIGURE 56
VITAMIN K2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 57
DATA TRIANGULATION
Growth opportunities and latent adjacency in Vitamin K2 Market